Dr. Peter L Oliver is a Visiting Associate Professor of Neuroscience at the University of Oxford (2018-). Peter completed a PhD at the MRC National Institute for Medical Research in 1999 where he studied the control of retroviral expression in the mouse genome. He then joined Professor Kay Davies' group in the MRC Functional Genomics Unit, Oxford, where he focused on studying gene function in the brain using mouse models. This included models of neurodegeneration as well as human behavioural disorders, such as schizophrenia. In 2013, he was awarded a European Research Council Starting (Consolidator) Grant and established his independent group in the Department of Physiology, Anatomy and Genetics, Oxford, to study a family of proteins (TLDc) that protect against oxidative stress in neurons. In 2017, he became an MRC Programme Leader at the MRC Mammalian Genetics Unit at Harwell, UK, focussing on new mouse models of TLDc-associated disorders, including neurodegeneration and epilepsy. In 2022, he became Head of Biology at the MRC Nucleic Acid Therapy Accelerator, a translational academic Unit focussing on RNA therapeutics combining novel chemistry and biology approaches, see: www.natahub.org